Bradley J Phd Bolzon's Net Worth
$154 Million
Who is Bradley J Phd Bolzon?
Bradley J Phd Bolzon has an estimated net worth of $154 Million. This is based on reported shares across multiple companies, which include Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, HELICOS BIOSCIENCES CORP, Alexza Pharmaceuticals Inc., Flexion Therapeutics Inc, Monte Rosa Therapeutics, Inc., CRISPR Therapeutics AG, Black Diamond Therapeutics, Inc., NOVACEA INC, and PHASERX, INC..
SEC CIK
Bradley J Phd Bolzon's CIK is 0001354345
Past Insider Trading and Trends
2020 was Bradley J Phd Bolzon's most active year for acquiring shares with 75 total transactions. Bradley J Phd Bolzon's most active month to acquire stocks was the month of October. 2020 was Bradley J Phd Bolzon's most active year for disposing of shares, totalling 191 transactions. Bradley J Phd Bolzon's most active month to dispose stocks was the month of October. 2016 saw Bradley J Phd Bolzon paying a total of $15,253,990.00 for 8,043,984 shares, this is the most they've acquired in one year. In 2021 Bradley J Phd Bolzon cashed out on 33,061,115 shares for a total of $43,786,895.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HELICOS BIOSCIENCES CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.32% | 242.93K |
$2.57 | $625,012.88 | 10.71M |
Sep 18
| |||
Form 4
| +403.73% | 8.62M |
—
|
—
| 10.76M |
Dec 23
| |||
Form 4
|
∞
| 2.14M |
$9.00 | $999,999.00 | 2.14M |
May 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inogen Inc (INGN) Snapshot price: $7.535
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -11.28% | -384.69K |
$24.30 | -$179,534.67 | 3.03M |
Nov 5 - Nov 7
| |||
Form 4
| -35.10% | -735.77K |
—
|
—
| 1.36M |
Jan 6 - Jan 7
| |||
Form 4
| -100.00% | -7.95K |
$30.98 | -$246,159.13 |
0
|
Jan 5
| |||
Form 4/A
| -18.22% | -478.05K |
—
|
—
| 2.15M |
Dec 18
| |||
Form 4
| -100.00% | -9.79K |
$29.74 | -$291,008.84 |
0
|
Dec 23
| |||
Form 4
| -18.22% | -478.05K |
—
|
—
| 2.15M |
Dec 18
| |||
Form 4
| -41.03% | -28.23K |
$24.80 | -$699,253.17 | 40.57K |
Nov 17 - Nov 19
| |||
Form 4
| -22.13% | -753.69K |
$25.13 | -$237,086.41 | 2.65M |
Nov 12 - Nov 14
| |||
Form 4
| -100.00% | -8.64K |
$24.53 | -$211,691.35 |
0
|
Nov 10
| |||
Form 4
| +4.31% | 4.44K |
$24.30 | -$179,534.67 | 107.47K |
Nov 5 - Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -77.05% | -51.70K |
—
|
—
| 15.4K |
Oct 7
| |||
| No matching records found | |||||||||
SECOND SIGHT MEDICAL PRODUCTS INC (VANI) Snapshot price: $1.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVACEA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.07M |
—
|
—
| 2.07M |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHASERX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.36% | 341.96K |
$2.51 | $2,997,419.56 | 1.94M |
May 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||